Journey Medical (DERM) Cash from Operations (2020 - 2026)
Journey Medical filings provide 6 years of Cash from Operations readings, the most recent being 6284000.0 for Q4 2025.
- On a quarterly basis, Cash from Operations fell 382.43% to 6284000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 12441000.0, a 36.31% decrease, with the full-year FY2025 number at 12441000.0, down 36.31% from a year prior.
- Cash from Operations hit 6284000.0 in Q4 2025 for Journey Medical, down from 2383000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 18747000.0 in Q3 2023 to a low of 16520000.0 in Q4 2023.
- Median Cash from Operations over the past 5 years was 2607500.0 (2025), compared with a mean of 1602150.0.
- Biggest five-year swings in Cash from Operations: surged 357.44% in 2023 and later tumbled 425.0% in 2024.
- Journey Medical's Cash from Operations stood at 3206000.0 in 2021, then dropped by 19.65% to 3836000.0 in 2022, then plummeted by 330.66% to 16520000.0 in 2023, then surged by 113.47% to 2225000.0 in 2024, then crashed by 382.43% to 6284000.0 in 2025.
- The last three reported values for Cash from Operations were 6284000.0 (Q4 2025), 2383000.0 (Q3 2025), and 942000.0 (Q2 2025) per Business Quant data.